Clinical Scorecard: The Influence of Weight Patterns on the Risk of Ten Different Cardiometabolic Disorders
At a Glance
Category
Detail
Condition
Cardiometabolic diseases associated with weight trajectory patterns
Key Mechanisms
Weight cycling alters body composition increasing fat vs lean mass, impairs glucose uptake and insulin action, promotes inflammation, and increases cardiometabolic risk independent of baseline BMI
Target Population
Adults with high baseline BMI undergoing weight changes (weight stable, gainers, losers, or cyclers)
Care Setting
Clinical care and weight management settings within comprehensive health systems
Key Highlights
Weight cycling increases risk for obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease, type 2 diabetes, and heart failure compared to weight stability.
Weight cycling risk is independent of baseline BMI and exceeds risks associated with weight gain or loss for some cardiometabolic diseases.
Weight cycling prevalence is high (27%-57%) and is linked to higher medication use for hypertension, dyslipidemia, and diabetes.
Guideline-Based Recommendations
Diagnosis
Assess longitudinal weight trajectory (stable, gain, loss, cycling) in adults with high BMI to stratify cardiometabolic risk.
Management
Promote weight stability at high BMI or sustained weight loss to reduce incidence of cardiometabolic diseases.
Address weight cycling behaviors due to their association with increased cardiometabolic risk.
Monitoring & Follow-up
Regularly monitor weight patterns over time to identify weight cycling and intervene accordingly.
Track cardiometabolic disease markers and medication use in patients with weight cycling.
Risks
Weight cycling is associated with nearly 30% increased risk for obstructive sleep apnea, steatotic liver disease, and type 2 diabetes.
Weight cycling confers over 50% increased risk for heart failure, higher than weight gain or loss alone.
Patient & Prescribing Data
Adults experiencing weight cycling with high baseline BMI
Weight cyclers are more likely to be prescribed medications for hypertension, dyslipidemia, and diabetes, indicating higher cardiometabolic disease burden.
Clinical Best Practices
Encourage maintenance of stable weight or sustained weight loss rather than repeated weight cycling.
Incorporate weight trajectory assessment into routine clinical evaluations for patients with obesity.
Consider the independent risk of weight cycling when managing cardiometabolic disease risk.
Use electronic health record data to identify patients with weight cycling for targeted interventions.
An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.
